Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Pittsburgh

Where translational science meets compassionate care

Pittsburgh’s strong foundation in biomedical research and clinical innovation makes it an ideal setting to bring together leaders in oncology, pathology, and precision medicine. This complimentary, CME-accredited conference will highlight emerging advances in molecular diagnostics, artificial intelligence–driven analysis, and biomarker-guided therapies that are reshaping cancer care.

The program will be co-chaired by Marija Balic, MD, PhD, MBA, Professor of Medicine at the University of Pittsburgh and a breast medical oncologist at UPMC Hillman Cancer Center, whose research focuses on translational breast cancer biology and the use of circulating tumor DNA and genomic technologies to guide therapy.

Joining her as co-chair is Adrian V. Lee, PhD, Pittsburgh Foundation Chair and Director of the Institute for Precision Medicine at the University of Pittsburgh, and Professor of Pharmacology & Chemical Biology and Human Genetics. Dr. Lee’s work focuses on translating molecular and genomic discoveries into precision therapies for breast cancer and improving the integration of genomics into clinical care.

Together with an expert faculty of clinicians and translational scientists, this program will explore how advances in diagnostics, genomics, and multidisciplinary collaboration are accelerating the delivery of personalized cancer treatment from the laboratory to the clinic.